Chromosomal instability by inefficient Mps1 auto-activation due to a weakened mitotic checkpoint and lagging chromosomes - PubMed (original) (raw)
Chromosomal instability by inefficient Mps1 auto-activation due to a weakened mitotic checkpoint and lagging chromosomes
Nannette Jelluma et al. PLoS One. 2008.
Abstract
Background: Chromosomal instability (CIN), a feature widely shared by cells from solid tumors, is caused by occasional chromosome missegregations during cell division. Two of the causes of CIN are weakened mitotic checkpoint signaling and persistent merotelic attachments that result in lagging chromosomes during anaphase.
Principal findings: Here we identify an autophosphorylation event on Mps1 that is required to prevent these two causes of CIN. Mps1 is phosphorylated in mitotic cells on at least 7 residues, 4 of which by autophosphorylation. One of these, T676, resides in the activation loop of the kinase domain and a mutant that cannot be phosphorylated on T676 is less active than wild-type Mps1 but is not kinase-dead. Strikingly, cells in which endogenous Mps1 was replaced with this mutant are viable but missegregate chromosomes frequently. Anaphase is initiated in the presence of misaligned and lagging chromosomes, indicative of a weakened checkpoint and persistent merotelic attachments, respectively.
Conclusions/significance: We propose that full activity of Mps1 is essential for maintaining chromosomal stability by allowing resolution of merotelic attachments and to ensure that single kinetochores achieve the strength of checkpoint signaling sufficient to prevent premature anaphase onset and chromosomal instability. To our knowledge, phosphorylation of T676 on Mps1 is the first post-translational modification in human cells of which the absence causes checkpoint weakening and CIN without affecting cell viability.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
Figure 1. Mps1 is phoshorylated during mitosis on at least 7 residues.
(A, B) A monoclononal Hela cell line stably expressing LAP-tagged Mps1 (HeLa-LAP-Mps1) was analyzed for expression level of LAP-Mps1 relative to endogenous Mps1 as shown by immunoblot (anti-Mps1) (A) and localization of LAP-Mps1 (anti-GFP) together with centromeres (ACA) and DNA (DAPI) (B). Scale bar is 5 µm. (C) List of phosphorylation sites identified by mass spectrometry on LAP-Mps1 isolated from mitotic HeLa-LAP-Mps1 cells (left column, in vivo) or on recombinant Mps1 isolated from insect cells (middle column, in vitro). Phosphorylation sites on recombinant Mps1 were designated ‘auto-phosphorylations’ when sites were not found on similarly expressed and isolated recombinant kinase-dead Mps1. (D) Schematic overview of phosphorylated residues on Mps1.
Figure 2. T676 phosphorylation is required for correct chromosome segregation and full checkpoint signaling.
(A) Expression levels, as shown by immunoblot (anti-Mps1), in asynchronously growing cells of LAP-Mps1 mutants (asterisk (*) indicates mutations that confer resistance to Mps1 shRNA) transiently transfected into U2OS cells. (B) Flow cytometric analysis of the fraction of mitotic cells transfected with Mock or Mps1 shRNA together with the indicated plasmids (asterisk (*) indicates mutations that confer resistance to Mps1 shRNA), and treated with nocodazole for 18 hrs. (C) Quantification of (B), average of three experiments (+/−SD). (D) U2OS cells transfected as in 2B were treated for 30 minutes with MG132. Fixed cells were stained with DAPI and the percentage of cells with all chromosomes aligned to the metaphase plate was determined (n = 30 cells). Graph represents the average of three experiments (+/−SD). (E) Mitotic progression of U2OS cells transfected as in 2B along with H2B-EYFP Mps1 was followed by live cell imaging. Stills from two representative cells showing anaphase with misaligned/lagging chromosomes (arrows) are shown (see Movie S1 and Movie S2). Scale bar is 5 µm. (F) Quantification of (E), average of three experiments (+/−SD), n = total amount of cells. (G) Graph showing the fraction of total missegregations as displayed in 2F with misaligned chromosomes, lagging chromosomes, or both in cells expressing Mps1-T676A.
Figure 3. Lack of T676 auto-phosphorylation reduces Mps1 kinase activity.
(A) Kinase activity of LAP-Mps1 mutants (asterisk (*) indicates mutations that confer resistance to Mps1 shRNA) extracted from mitotic U2OS cells was examined by in vitro kinase activity towards recombinant kinase-dead His-Mps1 (D664A). (B) Quantification of (A). Relative values to LAP-Mps1-WT were calculated after subtraction of the background signal derived from ‘mock’ immunoprecipitations (first lane in Fig. 3A). Average of three experiments (+/−SD). (C) Western blot showing phosphorylation specifically on T676 in lysates form U2OS cells transfected with the indicated constructs (asterisk (*) indicates mutations that confer resistance to Mps1 shRNA). (D) Western blot showing in vitro intermolecular auto-phosphorylation on T676. Combinations (as indicated) of recombinant wild-type GST-Mps1(-WT), kinase-dead GST- and His-Mps1(-KD) were subjected to a in vitro kinase reactions, after which proteins were analyzed for reactivity to pT676 antibody (green) and Mps1 antibody (red) by immunoblot.
Figure 4. T676 phosphorylation is required for maintaining chromosomal stability but not cell viability.
(A) U2OS cells were transfected as in 2B along with pBabe-puro, grown under puromycin selection for two weeks after which surviving colonies were stained. Immunoblot (anti-Mps1) shows expression levels in lysates taken 3 days after transfection of the different LAP-Mps1 mutants. (B) Quantification of the number of colonies counted in 4A, average of three experiments (+/−SD). (C) Immunoblot (anti-Mps1) showing expression levels of endogenous Mps1 and LAP-Mps1 in lysates of U2OS cells, and UTRM10 cells continuously expressing Mps1 shRNA through doxycycline treatment that stably express wild-type LAP-Mps1 (UTRM10-WT) or LAP-Mps1-T676A (UTRM10-T676A). (D) Graph shows average percentages of UTRM10-T676A and UTRM10-WT cells that missegregate chromosomes as observed with live cell imaging (as in 2E), (+/−SD), n = total amount of cells.
Similar articles
- Chk1 and Mps1 jointly regulate correction of merotelic kinetochore attachments.
Petsalaki E, Zachos G. Petsalaki E, et al. J Cell Sci. 2013 Mar 1;126(Pt 5):1235-46. doi: 10.1242/jcs.119677. Epub 2013 Jan 15. J Cell Sci. 2013. PMID: 23321637 - Autophosphorylation-dependent activation of human Mps1 is required for the spindle checkpoint.
Kang J, Chen Y, Zhao Y, Yu H. Kang J, et al. Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20232-7. doi: 10.1073/pnas.0710519105. Epub 2007 Dec 14. Proc Natl Acad Sci U S A. 2007. PMID: 18083840 Free PMC article. - Chemical genetic inhibition of Mps1 in stable human cell lines reveals novel aspects of Mps1 function in mitosis.
Sliedrecht T, Zhang C, Shokat KM, Kops GJ. Sliedrecht T, et al. PLoS One. 2010 Apr 22;5(4):e10251. doi: 10.1371/journal.pone.0010251. PLoS One. 2010. PMID: 20422024 Free PMC article. - Preventing aneuploidy: the contribution of mitotic checkpoint proteins.
Suijkerbuijk SJ, Kops GJ. Suijkerbuijk SJ, et al. Biochim Biophys Acta. 2008 Sep;1786(1):24-31. doi: 10.1016/j.bbcan.2008.04.001. Epub 2008 Apr 22. Biochim Biophys Acta. 2008. PMID: 18472014 Review.
Cited by
- Monopolar Spindle 1 Kinase (MPS1/TTK) mRNA Expression is Associated with Earlier Development of Clinical Symptoms, Tumor Aggressiveness and Survival of Glioma Patients.
Kessler AF, Feldheim J, Schmitt D, Feldheim JJ, Monoranu CM, Ernestus RI, Löhr M, Hagemann C. Kessler AF, et al. Biomedicines. 2020 Jul 3;8(7):192. doi: 10.3390/biomedicines8070192. Biomedicines. 2020. PMID: 32635204 Free PMC article. - Chromosome Instability; Implications in Cancer Development, Progression, and Clinical Outcomes.
Vishwakarma R, McManus KJ. Vishwakarma R, et al. Cancers (Basel). 2020 Mar 29;12(4):824. doi: 10.3390/cancers12040824. Cancers (Basel). 2020. PMID: 32235397 Free PMC article. Review. - Degree and site of chromosomal instability define its oncogenic potential.
Hoevenaar WHM, Janssen A, Quirindongo AI, Ma H, Klaasen SJ, Teixeira A, van Gerwen B, Lansu N, Morsink FHM, Offerhaus GJA, Medema RH, Kops GJPL, Jelluma N. Hoevenaar WHM, et al. Nat Commun. 2020 Mar 20;11(1):1501. doi: 10.1038/s41467-020-15279-9. Nat Commun. 2020. PMID: 32198375 Free PMC article. - Mps1-mediated release of Mad1 from nuclear pores ensures the fidelity of chromosome segregation.
Cunha-Silva S, Osswald M, Goemann J, Barbosa J, Santos LM, Resende P, Bange T, Ferrás C, Sunkel CE, Conde C. Cunha-Silva S, et al. J Cell Biol. 2020 Mar 2;219(3):e201906039. doi: 10.1083/jcb.201906039. J Cell Biol. 2020. PMID: 31913420 Free PMC article. - Checkpoint signaling and error correction require regulation of the MPS1 T-loop by PP2A-B56.
Hayward D, Bancroft J, Mangat D, Alfonso-Pérez T, Dugdale S, McCarthy J, Barr FA, Gruneberg U. Hayward D, et al. J Cell Biol. 2019 Oct 7;218(10):3188-3199. doi: 10.1083/jcb.201905026. Epub 2019 Sep 11. J Cell Biol. 2019. PMID: 31511308 Free PMC article.
References
- Heim S, Mitelman F. New York: Wiley Liss, Inc; 1995. Cancer Cytogenetics.
- Kops GJ, Weaver BA, Cleveland DW. On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer. 2005;5:773–785. - PubMed
- Ganem NJ, Storchova Z, Pellman D. Tetraploidy, aneuploidy and cancer. Curr Opin Genet Dev. 2007;17:157–162. - PubMed
- Weaver BA, Cleveland DW. Does aneuploidy cause cancer? Curr Opin Cell Biol. 2006;18:658–667. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials